SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Humana Names Dr. Andrew Agwunobi President of Company's Home Solutions Business

01/14/2022 | 10:31am EDT

Agwunobi has 20 years of experience as a CEO of for-profit, nonprofit, public and university health systems – bringing a balance of operational leadership and clinical expertise

Leading health insurer and health care services company Humana Inc. (NYSE: HUM) has hired health care industry veteran Andrew (Andy) Agwunobi, M.D., MBA, as the new President of the company’s Home Solutions business. Dr. Agwunobi comes to Humana from the University of Connecticut, where he currently serves as interim University President, and as CEO of the UConn Health System. In his new role, Dr. Agwunobi will report directly to Humana President and CEO Bruce Broussard and will serve as a member of Humana’s Management Team, effective Feb. 21.

This press release features multimedia. View the full release here:

Dr. Andrew Agwunobi (Photo: Business Wire)

Dr. Andrew Agwunobi (Photo: Business Wire)

“Andy is just the person we need for this critical Humana role leading our Home Solutions business,” Broussard said. “He has a real passion for care in the home. He has been responsible for a home health care organization as part of an integrated system. He has extensive operational experience with for-profit and nonprofit organizations, and he’s a doctor – he understands the value of care in the home, why seniors want more of it, and our vision at Humana for making it much easier for people to get the care they need at home.”

Prior to his years with UConn, Dr. Agwunobi led the 14-hospital St. Joseph Health System as COO, and led the 5-hospital Providence Health Care System as CEO. He also served as Secretary for the Florida Agency for Health Care Administration, where he had oversight for the state’s then $16 billion health care administration budget. More recently, as part of his UConn Health CEO role, Dr. Agwunobi has executed strategies that have resulted in significant revenue and operational growth. He also led the development of value-based care at UConn Health including Population Health Management.

Dr. Agwunobi’s strong clinical knowledge – with an aptitude for identifying clinical drivers of cost and opportunities to improve care and the member experience – will help him and his team lower the cost of care for Humana customers, while building a business model focused on patient health outcomes through at-home care.

“I’m excited about Humana’s focus on its Home Solutions business, and especially interested in ways we can transform the home health industry together,” Dr. Agwunobi said. “As the ongoing COVID pandemic has accelerated interest in and shifts to in-home care and home health models, I’m highly confident that we will be able to help the people we serve achieve better health outcomes. My experience to date has prepared me well for this new opportunity with Humana.”

Earlier in his life, after growing up in Scotland and Nigeria, Agwunobi pursued medical student training in Nigeria, and then Scotland. He is a pediatrician who earned his M.D. from the University of Jos in Nigeria, and later an MBA from Stanford University. He completed his residency in pediatrics at Howard University Hospital.

Dr. Agwunobi currently serves on the board of CareQuest. He has most recently served on the Dignity Community Care and Restorix Health boards.

About Humana

Humana Inc. (NYSE: HUM) is committed to helping our millions of medical and specialty members achieve their best health. Our successful history in care delivery and health plan administration is helping us create a new kind of integrated care with the power to improve health and well-being and lower costs. Our efforts are leading to a better quality of life for people with Medicare, families, individuals, military service personnel, and communities at large.

To accomplish that, we support physicians and other health care professionals as they work to deliver the right care in the right place for their patients, our members. Our range of clinical capabilities, resources and tools – such as in-home care, behavioral health, pharmacy services, data analytics and wellness solutions – combine to produce a simplified experience that makes health care easier to navigate and more effective.

More information regarding Humana is available to investors via the Investor Relations page of the company’s web site at, including copies of:

  • Annual reports to stockholders
  • Securities and Exchange Commission filings
  • Most recent investor conference presentations
  • Quarterly earnings news releases and conference calls
  • Calendar of events
  • Corporate Governance information


ę Business Wire 2022
All news about HUMANA INC.
05/16Humana's CenterWell Senior Primary Care Enters Joint Venture With Welsh, Carson, Anders..
05/16Humana's CenterWell Senior Primary Care and Welsh, Carson, Anderson & Stowe Announce Se..
05/16Humana Inc. and Welsh, Carson, Anderson & Stowe Announce Second Joint Venture to Develo..
05/11Humana To Acquire Swedish Assistance Provider For $15 Million
05/10TRANSCRIPT : Humana Inc. Presents at Bank of America 2022 Healthcare Conference, May-10-20..
05/10Humana Specialty Pharmacy Receives Prestigious National Patient Choice Award for Fifth ..
05/05INSIDER SELL : Humana
05/03Skylight Health Group Executes Definitive Agreement to Buy NeighborMD to Expand in Flor..
05/02INSIDER SELL : Humana
05/02INSIDER SELL : Humana
More news
Analyst Recommendations on HUMANA INC.
More recommendations
Financials (USD)
Sales 2022 92 987 M - -
Net income 2022 2 969 M - -
Net Debt 2022 6 396 M - -
P/E ratio 2022 17,9x
Yield 2022 0,72%
Capitalization 53 132 M 53 132 M -
EV / Sales 2022 0,64x
EV / Sales 2023 0,58x
Nbr of Employees 95 500
Free-Float 63,6%
Duration : Period :
Humana Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HUMANA INC.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 22
Last Close Price 420,04 $
Average target price 501,60 $
Spread / Average Target 19,4%
EPS Revisions
Managers and Directors
Bruce Dale Broussard President, Chief Executive Officer & Director
Susan M. Diamond Chief Financial Officer
Kurt J. Hilzinger Chairman
Sam Deshpande Chief Information Officer
Alefiyah Mesiwala Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
HUMANA INC.-5.02%55 732
ANTHEM, INC.6.48%119 865